First issue, Vol. 1, No. 1 (January–June 2026), will be published in April 2026.
The Article Processing Charge (APC) is waived for submissions until 31 May 2026.
Aims and Scope
Aim of JAPT
The journal aims to provide a high-quality, peer-reviewed international forum for advanced research in pharmaceutical sciences and therapeutic innovation, fostering the development and dissemination of novel drug discovery, formulation sciences, pharmacology, and therapeutic strategies that address current and emerging health challenges. It supports interdisciplinary collaboration among pharmaceutical scientists, clinicians, biomedical researchers, and healthcare professionals, promoting rigorous, evidence-based research that bridges laboratory findings with clinical and therapeutic applications. The journal encourages innovation in drug delivery systems, biologics, small molecule therapeutics, and translational research to improve patient outcomes, ensuring the publication of original research, reviews, technical reports, case studies, and short communications with methodological integrity and ethical standards. By facilitating global access to cutting-edge pharmaceutical research and promoting knowledge exchange across institutions and countries, the journal contributes to the advancement of pharmaceutical science and therapeutics, ultimately enhancing public health and patient care worldwide.
Scope of JAPT
JAPT welcomes submissions in (but not limited to) the following broad subject areas:
1. Drug discovery and design — medicinal chemistry, computational drug design, lead optimization.
2. Pharmacology and pharmacodynamics/pharmacokinetics — preclinical and clinical pharmacology, ADME, drug metabolism, dose–response studies.
3. Drug formulation and delivery systems — novel dosage forms, controlled release, nanomedicine, targeted drug delivery, sustained‑release formulations.
4. Biotechnology and biologics — therapeutic proteins, antibodies, peptides, gene therapy, vaccine development.
5. Pharmacogenomics and personalized medicine — genetic influences on drug response, biomarker-driven therapy, precision therapeutics.
6. Toxicology and safety evaluation — in vitro/in vivo toxicology studies, safety pharmacology, adverse‑effect profiling, risk assessment.
7. Clinical studies and translational research — translational drug development, clinical trials, therapeutic evaluations, case reports.
8. Pharmaceutical quality control and regulatory science — drug stability, formulation quality, regulatory compliance, GMP aspects.
9. Drug‑drug interactions, combination therapies, and polypharmacy research.
10. Natural products, phytochemistry, herbal drug research, traditional medicine integration, and pharmacognosy.
11. Drug delivery for special populations — pediatrics, geriatrics, women’s health, chronic disease management.
12. Pharmacoeconomics, health outcomes research, access to medicines, public‑health pharmacology, and global health therapeutics.
13. Novel therapeutic strategies — targeted therapies, immunotherapies, advanced therapeutics for infectious and chronic diseases.
14. Biotechnology‑driven formulation technologies — liposomes, nanoparticles, polymeric carriers, controlled‑release systems.
15. Ethical, social and regulatory aspects of drug development — ethical trials, access, drug safety, patient-focused therapeutic research.
